Abstract
Neurodegenerative diseases are phenomena that occur in the central nervous system through the hallmarks associating the loss of neuronal structure and function. These diseases affect many of our body’s activities, such as balance, movement, talking, breathing, and heart function. These disorders are very common and their frequency increases with age, in mid-to-late adult life. Except neurodegeneration, a very common disease is diabetes mellitus. Diabetes mellitus is a chronic disease caused by inherited and/or acquired deficiency in the production of insulin by the pancreas or by the ineffectiveness of the insulin produced. Such a deficiency results in increased concentrations of glucose in the blood, which in turn damage many of the body’s systems. Since the past few decades, diabetes has become a global health problem. Apart from conventional therapy, several studies have shown that some natural products have beneficial effects in neurological and diabetic patients. Various natural products emerged as interesting molecules with antineurodegenerative and antidiabetic potential. However, little is known in relation to lichens as potential therapeutics in these disorders. Therefore, this chapter focuses on the antineurodegenerative and antidiabetic potential of lichens that have received considerable attention in the recent past.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abusufyan S, Ibrahim M, Mohib K (2018) Comparative in vitro antidiabetic and antioxidant activity of various extracts of Ficus species. Pharm J 10:349–354
Ataie A, Shadifar M, Ataee R (2016) Polyphenolic antioxidants and neuronal regeneration. Basic Clin Neurosci 7:81–90
Barquilla García A (2017) Brief update on diabetes for general practitioners. Rev Esp Sanid Penit 19:57–65
Baynes HW (2015) Classification, pathophysiology, diagnosis and management of diabetes mellitus. J Diabetes Metab 6:541
Behera BC, Adawadkar B, Makhija U (2004) Capacity of some Graphidaceous lichens to scavenge superoxide and inhibition of tyrosinase and xanthine oxidase activities. Curr Sci 87:83–87
Berger J, Wagner JA (2002) Physiological and therapeutic roles of peroxisome proliferatoractivated receptors. Diabetes Technol Ther 4:163–174
Chonpathompikunlert P, Boonruamkaew P, Sukketsiri W et al (2018) The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice. BMC Complement Altern Med 18:103
Choudhary MI, Ali M, Wahab AT et al (2011) New antiglycation and enzyme inhibitors from Parmotrema cooperi. Sci China Chem 54:1926–1931
Crous-Bou M, Minguillón C, Gramunt N et al (2017) Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimers Res Ther 9:71
Cui Y, Yim JH, Lee DS et al (2012) New diterpene furanoids from the Antarctic lichen Huea sp. Bioorg Med Chem Lett 22:7393–7396
de Paz GA, Raggio J, Gómez-Serranillos MP et al (2010) HPLC isolation of antioxidant constituents from Xanthoparmelia spp. J Pharm Biomed Anal 53:165–171
Dsouza D, Lakshmidevi N (2015) Models to study in vitro antidiabetic activity of plants: a review. Int J Pharm Biol Sci 6:732–741
Ellman GL, Courtney DK, Andreas V et al (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Emsen B, Aslan A, Togar B et al (2016) In vitro antitumor activities of the lichen compounds olivetoric, physodic and psoromic acid in rat neuron and glioblastoma cells. Pharm Biol 54:1748–1762
Evans RM, Barish GD, Wang YX (2004) PPARs and the complex journey to obesity. Nat Med 10:355–361
Fernandez-Moriano C, Divakar PK, Crespo A et al (2015) Neuroprotective activity and cytotoxic potential of two Parmeliaceae lichens: identification of active compounds. Phytomedicine 22:847–855
Fernández-Moriano C, Divakar PK, Crespo A et al (2017) In vitro neuroprotective potential of lichen metabolite fumarprotocetraric acid via intracellular redox modulation. Toxicol Appl Pharmacol 316:83–94
Griess P (1879) Bemerkungen zu der abhandlung der H.H. Weselsky und Benedikt “Ueber einige azoverbindungen”. Chem Ber 12:426–428
Gupta RC, Chang D, Nammi S et al (2017) Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetol Metab Syndr 9:59
Haj FG, Markova B, Klaman LD et al (2003) Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 278:739–744
Hengameh P, Shivanna R, Rajkumar HG (2016) In-vitro inhibitory activity of some lichen extracts against FC;-amylase enzyme. Eur J Biomed Pharm Sci 3:315–318
Hippius H, Neundörfer G (2003) The discovery of Alzheimer’s disease. Dialogues Clin Neurosci 5:101–108
Honda NK, Gonçalves K, Brandão LZG et al (2016) Screening of lichen extracts using tyrosinase inhibition and toxicity against Artemia salina. Orbital Electron J Chem 8:181–188
Ikeda T, Yamada M (2010) Risk factors for Alzheimer’s disease. Brain Nerve 62:679–690
Jack CR Jr, Albert MS, Knopman DS et al (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:257–262
Karunaratne V, Thadhani VM, Khan SN et al (2014) Potent FC;-glucosidase inhibitors from the lichen Cladonia species from Sri Lanka. J Natl Sci Found Sri Lanka 42:95–98
Khan MF, Rawat AK, Khatoon S et al (2018) In vitro and in vivo antidiabetic effect of extracts of Melia azedarach, Zanthoxylum alatum, and Tanacetum nubigenum. Integr Med Res 7:176–183
Kim GH, Kim JE, Rhie SJ et al (2015) The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol 24:325–340
Kim M, Ho A, Lee JH (2017) Autophagy and human neurodegenerative diseases—a fly’s perspective. Int J Mol Sci 18:1596
Kremens D, Hauser RA, Dorsey ER (2014) An update on Parkinson’s disease: improving patient outcomes. Am J Med 127:S3
Liu Z, Zhou T, Ziegler AC et al (2017) Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev 2017:2525967
Luo H, Li C, Kim JC et al (2013) Biruloquinone, an acetylcholinesterase inhibitor produced by lichen-forming fungus Cladonia macilenta. J Microbiol Biotechnol 23:161–166
Parimelazhagan T (2016) Anti-diabetic activity. In: Parimelazhagan T (ed) Pharmacological assays of plant-based natural products. Springer, Cham, pp 139–143
Paudel B, Bhattarai HD, Koh HY et al (2011) Ramalin, a novel nontoxic antioxidant compound from the Antarctic lichen Ramalina terebrata. Phytomedicine 184:1285–1290
Paulson HL (2009) The spinocerebellar ataxias. J Neuroophthalmol 29:227–237
Pejin B, Tommonaro G, Iodice C et al (2013) A new depsidone of Lobaria pulmonaria with acetylcholinesterase inhibition activity. J Enzyme Inhib Med Chem 28:876–878
Pratt AJ, Getzoff ED, Perry JJ (2012) Amyotrophic lateral sclerosis: update and new developments. Degener Neurol Neuromuscul Dis 2:1–14
Reddy RG, Veeraval L, Maitra S et al (2016) Lichen-derived compounds show potential for central nervous system therapeutics. Phytomedicine 23:1527–1534
Roos RA (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5:40
Saito K, Lee S, Shiuchi T et al (2011) An enzymatic photometric assay for 2-deoxyglucose uptake in insulin-responsive tissues and 3T3-L1 adipocytes. Anal Biochem 412:9–17
Seo C, Choi YH, Ahn JS et al (2009a) PTP1B inhibitory effects of tridepside and related metabolites isolated from the Antarctic lichen Umbilicaria antarctica. J Enzyme Inhib Med Chem 24:1133–1137
Seo C, Sohn JH, Ahn JS et al (2009b) Protein tyrosine phosphatase 1B inhibitory effects of depsidone and pseudodepsidone metabolites from the Antarctic lichen Stereocaulon alpinum. Bioorg Med Chem Lett 19:2801–2803
Seo C, Yim JH, Lee HK et al (2011) PTP1B inhibitory secondary metabolites from the Antarctic lichen Lecidella carpathica. Mycology 2:18–23
Shivanna R, Hengameh P, Rajkumar HG (2015) Screening of lichen extracts for in-vitro antidiabetic activity using alpha amylase inhibitory assay. Int J Biol Pharm Res 6:364–367
Thadhani VM (2013) Semisynthesis and bioactivities of lichen metabolites. Scholars’ Press, Saarbrücken
Thadhani VM, Karunaratne V (2017) Potential of lichen compounds as antidiabetic agents with antioxidative properties: a review. Oxid Med Cell Longev 2017:2079697
Thadhani VM, Naaz Q, Choudhag MI et al (2014) Enzyme inhibitory and immunomodulatory activities of the depsidone lobaric acid extracted from the lichen Heterodermia sp. J Natl Sci Found Sri Lanka 42:193–196
Valadbeigi T (2016) Chemical composition and enzymes inhibitory, brine shrimp larvae toxicity, antimicrobial and antioxidant activities of Caloplaca biatorina. Zahedan J Res Med Sci 18:e4267
Valadbeigi T, Shaddel M (2016) Amylase inhibitory activity of some macro lichens in Mazandaran province, Iran. Physiol Pharmacol 20:215–219
Valley MP, Karassina N, Aoyama N et al (2016) A bioluminescent assay for measuring glucose uptake. Anal Biochem 505:43–50
Verma N, Behera BC, Sonone A et al (2008) Lipid peroxidation and tyrosinase inhibition by lichen symbionts grown in vitro. Afr J Biochem Res 2:225–231
Verma N, Behera BC, Om Sharma B (2012) Glucosidase inhibitory and radical scavenging properties of lichen metabolites salazinic acid, sekikaic acid and usnic acid. Hacettepe J Biol Chem 40:7–21
Villhauer EB, Brinkman JA, Naderi GB et al (2003) 1-[(3-hydroxy-1 adamantyl) amino acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J Med Chem 46:2774–2789
Vinayaka KS, Karthik S, Nandini KC et al (2013) Amylase inhibitory activity of some macrolichens of western ghats, Karnataka, India. Indian J Novel Drug Deliv 5:225–228
Yamamoto N, Ueda-Wakagi M, Sato T et al (2015) Measurement of glucose uptake in cultured cells. Curr Protoc Pharmacol 71:12.14.1–12.14.26
Zlatanović I, Stanković M, Stankov-Jovanović V et al (2017) Biological activities of Umbilicaria crustulosa (Ach.) Frey acetone extract. J Serb Chem Soc 82:141–150
Zrnzević I, Stanković M, Stankov Jovanovic V et al (2017) Ramalina capitata (Ach.) Nyl. acetone extract: HPLC analysis, genotoxicity, cholinesterase, antioxidant and antibacterial activity. EXCLI J 16:679–687
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kosanić, M., Ranković, B. (2019). Antineurodegenerative and Antidiabetic Activity of Lichens. In: Ranković, B. (eds) Lichen Secondary Metabolites. Springer, Cham. https://doi.org/10.1007/978-3-030-16814-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-16814-8_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16813-1
Online ISBN: 978-3-030-16814-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)